Page last updated: 2024-11-05

ticlopidine and Pneumonia, Pneumococcal

ticlopidine has been researched along with Pneumonia, Pneumococcal in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.

Research Excerpts

ExcerptRelevanceReference
"In patients, thrombocytopenia is correlated with an adverse outcome of pneumonia."1.42Thrombocytopenia impairs host defense during murine Streptococcus pneumoniae pneumonia. ( Brands, X; de Stoppelaar, SF; Roelofs, JJ; Schouten, M; Schultz, MJ; van den Boogaard, FE; van der Poll, T; van't Veer, C, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van den Boogaard, FE1
Schouten, M1
de Stoppelaar, SF1
Roelofs, JJ1
Brands, X1
Schultz, MJ1
van't Veer, C1
van der Poll, T1

Other Studies

1 other study available for ticlopidine and Pneumonia, Pneumococcal

ArticleYear
Thrombocytopenia impairs host defense during murine Streptococcus pneumoniae pneumonia.
    Critical care medicine, 2015, Volume: 43, Issue:3

    Topics: Animals; Antithrombin III; Clopidogrel; Cytokines; Disease Models, Animal; Mice; Peptide Hydrolases;

2015